Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to Board of Directors
HAMILTON, Ontario and BOSTON, Feb. 11, 2021 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the appointment of Philina Lee, Ph.D., as a member…
Comments Off on Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to Board of Directors